DiaMedica Therapeutics Inc. (DMAC) Net Margin (2018)
DiaMedica Therapeutics (DMAC) has 1 years of Net Margin data on record, last reported at 277.4% in Q3 2018.
- For Q3 2018, Net Margin changed N/A year-over-year to 277.4%; the TTM value through Jun 2019 reached 1814.2%, changed N/A, while the annual FY2024 figure was 71894.12%, 1620134.0% down from the prior year.
- Net Margin reached 277.4% in Q3 2018 per DMAC's latest filing.
- Across five years, Net Margin topped out at 277.4% in Q3 2018 and bottomed at 277.4% in Q3 2018.